0
ARTICLE |

Hereditary Hemochromatosis FREE

Tracey A. Rouault, MD
[+] Author Affiliations

Reprint requests to National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892 (Dr Rouault).


JAMA. 1993;269(24):3152-3154. doi:10.1001/jama.1993.03500240096033
Text Size: A A A
Published online

SELECTED CASE  A 44-year-old man had shoulder and finger pain and consulted his local physician. Screening blood tests were obtained as part of the initial evaluation and revealed the following values: hemoglobin, 135 g/L; hematocrit, 0.40; serum iron, 37 μmol/L (209 μg/dL); transferrin, 2.19 g/L; transferrin saturation, 95%; and serum ferritin, 2430 μg/L. Liver function tests revealed the following values: aspartate aminotransferase, 43 U/L; alanine aminotranferase, 68 U/L; and alkaline phosphatase and bilirubin, normal. A liver biopsy was performed and examination of tissue sections revealed fatty metamorphosis and an increase in fibrous tissue in portal areas consistent with early cirrhosis. Large amounts of parenchymal iron were noted on Prussian blue staining, particularly in the periportal area.The diagnosis based on the test results was hemochromatosis, and a phlebotomy program was initiated. The patient was referred to the National Institutes of Health where on physical examination the absence of frank arthritis

REFERENCES

Bothwell TH, Charlton RW, Motulsky AG.  Idiopathic hemochromatosis.  In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The Metabolic Basis of Inherited Disease . New York, NY: McGraw-Hill International Book Co; 1983;:1269-1298.
Smith LH.  Overview of hemochromatosis. West J Med . 1990;;153:296-308.
Crawford DHG, Halliday JW.  Current concepts in rational therapy for haemochromatosis. Drugs . 1991;;41:875-882.
Crawford R. The Iron Elephant . Glyndon, Md: Bida Publishing; 1992;.
Adams PC, Kertesz AE, Valberg LS.  Clinical presentation of hemochromatosis: a changing scene. Am J Med . 1991;;90:445-449.
Cox TM, Lord DK.  Hereditary hemochromatosis. Eur J Haematol . 1989;;42:113-125.
Milder MS, Cook JD, Stray S, Finch CA.  Idiopathic hemochromatosis: an interim report. Medicine . 1980;;59:34-47.
Idzerda RL, Huebers H, Finch CA, McKnight GS.  Rat transferrin gene expression: tissue-specific regulation by iron deficiency. Proc Natl Acad Sci U S A . 1986;;83:3723-3727.
Niederau C, Rudolf F, Sonnenberg A, Trampisch HJ.  Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary haemochromatosis. N Engl J Med . 1985;;313:1256-1262.
Simon M, Yaouanq J, Fauchet R, Le Gall JY, Brissot P, Bourel M.  Genetics of hemochromatosis: HLA association and mode of inheritance. Ann N Y Acad Sci . 1988;;526:11-22.
Cook JD.  Adaptation in iron metabolism. Am J Clin Nutr . 1990;;51:301-308.
Granick S.  Increase of the protein apoferritin in the gastrointestinal mucosa as a direct response to iron feeding: the function of ferritin in the regulation of iron absorption. J Biol Chem . 1946;;164:737-746.
Conrad ME, Crosby WH.  Intestinal mucosal mechanisms controlling iron absorption. Blood . 1963;; 22:406-415.
Bacon BR, Britton RS.  The pathology of hepatic iron overload: a free radical-mediated process? Hepatology . 1990;;11:127-137.
Schumacher HR, Straka PC, Krikker MA, Dudley AT.  The arthropathy of hemochromatosis: recent studies. Ann N Y Acad Sci . 1988;;526:224-233.
Kelly TM, Edwards CQ, Meikle AW, Kushner JP.  Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med . 1984;;101:629-632.
Siemons LJ, Mahler CH.  Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion. J Clin Endocrinol Metab . 1987;;65:585-587.
Gordeuk V, Mukiibi J, Hasstedt SJ, et al.  Iron overload in Africa: interaction between a gene and dietary iron. N Engl J Med . 1992;;326:95-100.
Haile DJ, Rouault TA, Tang CK, Chin J, Harford JB, Klausner RD.  Reciprocal control of RNA binding and aconitase activity in the regulation of the iron responsive element binding protein: role of the iron-sulfur cluster. Proc Natl Acad Sci U S A . 1992;;89:7536-7540.
Jankovic GM, Colovic MD, Petrovic MD, et al.  Selective advantage for females with h-allele? Eur J Haematol . 1989;;43:265-266.
Jankovic GM, Petrovic MD, Colovic MD, Milosevic RA, Janosevic S, Trpinac DP.  Increased transplacental and breast milk iron delivery in hereditary hemochromatosis: an evolutionary enigma resolved? Am J Hematol . 1991;;38:153-155.
Salonen JT, Nyyssonen K, Korpela H, Tuomelehto J, Seppanen R, Salonen R.  High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation . 1992;; 86:803-811.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Bothwell TH, Charlton RW, Motulsky AG.  Idiopathic hemochromatosis.  In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS, eds. The Metabolic Basis of Inherited Disease . New York, NY: McGraw-Hill International Book Co; 1983;:1269-1298.
Smith LH.  Overview of hemochromatosis. West J Med . 1990;;153:296-308.
Crawford DHG, Halliday JW.  Current concepts in rational therapy for haemochromatosis. Drugs . 1991;;41:875-882.
Crawford R. The Iron Elephant . Glyndon, Md: Bida Publishing; 1992;.
Adams PC, Kertesz AE, Valberg LS.  Clinical presentation of hemochromatosis: a changing scene. Am J Med . 1991;;90:445-449.
Cox TM, Lord DK.  Hereditary hemochromatosis. Eur J Haematol . 1989;;42:113-125.
Milder MS, Cook JD, Stray S, Finch CA.  Idiopathic hemochromatosis: an interim report. Medicine . 1980;;59:34-47.
Idzerda RL, Huebers H, Finch CA, McKnight GS.  Rat transferrin gene expression: tissue-specific regulation by iron deficiency. Proc Natl Acad Sci U S A . 1986;;83:3723-3727.
Niederau C, Rudolf F, Sonnenberg A, Trampisch HJ.  Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary haemochromatosis. N Engl J Med . 1985;;313:1256-1262.
Simon M, Yaouanq J, Fauchet R, Le Gall JY, Brissot P, Bourel M.  Genetics of hemochromatosis: HLA association and mode of inheritance. Ann N Y Acad Sci . 1988;;526:11-22.
Cook JD.  Adaptation in iron metabolism. Am J Clin Nutr . 1990;;51:301-308.
Granick S.  Increase of the protein apoferritin in the gastrointestinal mucosa as a direct response to iron feeding: the function of ferritin in the regulation of iron absorption. J Biol Chem . 1946;;164:737-746.
Conrad ME, Crosby WH.  Intestinal mucosal mechanisms controlling iron absorption. Blood . 1963;; 22:406-415.
Bacon BR, Britton RS.  The pathology of hepatic iron overload: a free radical-mediated process? Hepatology . 1990;;11:127-137.
Schumacher HR, Straka PC, Krikker MA, Dudley AT.  The arthropathy of hemochromatosis: recent studies. Ann N Y Acad Sci . 1988;;526:224-233.
Kelly TM, Edwards CQ, Meikle AW, Kushner JP.  Hypogonadism in hemochromatosis: reversal with iron depletion. Ann Intern Med . 1984;;101:629-632.
Siemons LJ, Mahler CH.  Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion. J Clin Endocrinol Metab . 1987;;65:585-587.
Gordeuk V, Mukiibi J, Hasstedt SJ, et al.  Iron overload in Africa: interaction between a gene and dietary iron. N Engl J Med . 1992;;326:95-100.
Haile DJ, Rouault TA, Tang CK, Chin J, Harford JB, Klausner RD.  Reciprocal control of RNA binding and aconitase activity in the regulation of the iron responsive element binding protein: role of the iron-sulfur cluster. Proc Natl Acad Sci U S A . 1992;;89:7536-7540.
Jankovic GM, Colovic MD, Petrovic MD, et al.  Selective advantage for females with h-allele? Eur J Haematol . 1989;;43:265-266.
Jankovic GM, Petrovic MD, Colovic MD, Milosevic RA, Janosevic S, Trpinac DP.  Increased transplacental and breast milk iron delivery in hereditary hemochromatosis: an evolutionary enigma resolved? Am J Hematol . 1991;;38:153-155.
Salonen JT, Nyyssonen K, Korpela H, Tuomelehto J, Seppanen R, Salonen R.  High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation . 1992;; 86:803-811.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.